Back

Guideline directed medical therapy in patients with heart failure with reduced ejection fraction undergoing renal replacement therapy: real world experience from a specialized cardiorenal unit

9 May 2026 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Advanced pharmacotherapy in complex heart failure scenarios Comorbidities Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Sonia Ruiz Bustillo

Hospital del Mar, Barcelona (Spain)

6 More presentations in this session

Presentation thumbnail
Efficacy and safety of sacubitril-valsartan versus enalapril in patients with heart failure due to Chagas cardiomyopathy: a systematic review and meta-analysis
Doctor B. Aziri (Sarajevo, BA)
Abstract Slides Video
Presentation thumbnail
Improved subgroup treatment effect estimation in heart failure trials using Bayesian hierarchical shrinkage models
Doctor A. Henderson (Glasgow, GB)
Abstract Slides Video
Presentation thumbnail
Sacubitril/valsartan, initial dip in estimated glomerular filtration rate, and clinical outcomes in patients with heart failure
Doctor M. Manabe (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Effect of sacubitril/valsartan and SGLT2 inhibitors on echocardiographic response and clinical outcomes after cardiac resynchronization therapy: insights from a real-world cohort
Doctor I. Martins Moreira (Vila Real, PT)
Abstract Slides Video
Presentation thumbnail
Efficacy and safety of sacubitril/valsartan in the management of heart failure with reduced ejection fraction and chronic kidney disease: a systematic review and meta-analysis
Doctor B. Chan Chin (Limerick, IE)
Abstract Slides Video

Access the full session

Session thumbnail
Advanced pharmacotherapy in complex heart failure scenarios

The Event

Event poster

Heart Failure 2026

9 May - 12 May 2026
You may be interested in
thumbnail
Congress Presentation
Optimising heart failure treatment in patients receiving renal replacement therapy: the role of a cardiorenal unit
thumbnail
Congress Presentation
Initiation and titration of prognostic drug therapy during hospitalization for acute decompensation of heart failure with reduced ejection fraction
thumbnail
Congress Presentation
Implementation of recommendations regarding pharmacotherapy optimization in patients with heart failure undergoing scheduled hospitalization - the HEROES study.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources